Percutaneous radiofrequency ablation for atrial fibrillation
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ipg168
1.1 Current evidence on the safety and efficacy of percutaneous radiofrequency ablation for atrial fibrillation appears adequate to support the use of this procedure in appropriately selected patients (see section 2.1.4) provided that normal arrangements are in place for audit and clinical governance.
1.2 Clinicians should ensure that patients fully understand the potential complications, the likelihood of success and the risk of recurrent atrial fibrillation associated with this procedure. In addition, use of the Institute's information for the public is recommended.
1.3 This procedure should only be performed in specialist units and with arrangements for cardiac surgical support in the event of complications.
1.4 This procedure should only be performed by cardiologists with extensive experience of other types of ablation procedures.
1.5 The Department of Health runs the Central Cardiac Audit Database (CCAD), and clinicians are encouraged to enter all patients undergoing percutaneous radiofrequency ablation for atrial fibrillation onto this database.